How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
P Póvoa, L Coelho, F Dal-Pizzol, R Ferrer… - Intensive care …, 2023 - Springer
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host
response to infection. In this context, biomarkers could be considered as indicators of either …
response to infection. In this context, biomarkers could be considered as indicators of either …
[HTML][HTML] Natural therapeutics and nutraceuticals for lung diseases: traditional significance, phytochemistry, and pharmacology
Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases …
JP Metlay, GW Waterer, AC Long… - American journal of …, 2019 - atsjournals.org
Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …
management of adult patients with community-acquired pneumonia. Methods: A …
Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis
IS Kamat, V Ramachandran, H Eswaran… - Clinical Infectious …, 2020 - academic.oup.com
Because of the diverse etiologies of community-acquired pneumonia (CAP) and the
limitations of current diagnostic modalities, serum procalcitonin levels have been proposed …
limitations of current diagnostic modalities, serum procalcitonin levels have been proposed …
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
I Martin-Loeches, A Torres, B Nagavci, S Aliberti… - Intensive care …, 2023 - Springer
Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …
and mortality, and whilst European and non-European guidelines are available for …
Procalcitonin: where are we now?
B Hamade, DT Huang - Critical Care Clinics, 2020 - criticalcare.theclinics.com
Procalcitonin (PCT) is a protein that consists of 116 amino acids and is the peptide precursor
of calcitonin. Calcitonin is initially biosynthesized as PCT, which, under normal conditions, is …
of calcitonin. Calcitonin is initially biosynthesized as PCT, which, under normal conditions, is …
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
I Pink, D Raupach, J Fuge, RP Vonberg, MM Hoeper… - Infection, 2021 - Springer
Abstract Purpose Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
coronavirus 2 (SARS-CoV-2) has spread around the world. Differentiation between pure …
coronavirus 2 (SARS-CoV-2) has spread around the world. Differentiation between pure …
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients
R Carbonell, S Urgelés, M Salgado, A Rodríguez… - Journal of Infection, 2022 - Elsevier
ABSTRACT Background: Procalcitonin (PCT) and C-Reactive Protein (CRP) are useful
biomarkers to differentiate bacterial from viral or fungal infections, although the association …
biomarkers to differentiate bacterial from viral or fungal infections, although the association …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Purpose Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19
J Han, T Gatheral, C Williams - Clinical Medicine, 2020 - rcpjournals.org
1 Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of
2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 …
2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 …